Drug intelligence / Profile preview

insulin + glucose (University of Missouri)

Development stage
Phase 1
Lead developer
University of Missouri
Modality
Small Molecules
Administration
Intravenous
01

Overview

The hyperinsulinemic-euglycemic infusion, commonly known as the 'clamp' technique, is a clinical procedure used to measure insulin sensitivity and metabolic response. In the context of research at the University of Missouri-Columbia, this intervention is utilized as a mechanistic tool to study the physiological effects of insulin in individuals with obesity, specifically focusing on its role in modulating blood flow and sympathetic nervous system activity. The procedure involves the simultaneous intravenous administration of insulin to raise systemic insulin levels (hyperinsulinemia) and glucose (dextrose) at a variable rate to maintain normal blood sugar levels (euglycemia). By titrating the glucose infusion rate to match the rate of insulin-stimulated glucose uptake, researchers can quantify the degree of insulin resistance. This specific study (NCT01142635) also investigated how these responses are influenced by endothelin-1 (ET-1) signaling.

Other names
Hyperinsulinemic, euglycemic infusionHyperinsulinemic-euglycemic clampInsulin-glucose infusion
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on insulin + glucose (University of Missouri).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on insulin + glucose (University of Missouri).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call